±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1300  |  »Ø¸´: 6
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ÏÄÌìÏÂÓêÁË

¹ÜÀíÔ±

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡


[½»Á÷] ÖÐÒëÓ¢£¨Ò©´ú·½ÃæµÄ£©

¶à¼ÁÁ¿¿Ú·þ10mgÁ½ÖÖÖÆ¼Á£¬Ã¿ÈÕÒ»´Î£¬Ã¿´Î10mg£¬ÓÚ·þÒ©ºóµÚ4ÌìѪҩŨ¶È´ïÎÈ̬¡£Á½ÖÖÖÆ¼ÁµÄFֵΪ98.9%¡À7.9%£¬²ÎÊýTmax£¬Cmax£¬Cmin£¬AUCss£¬AUMCss£¬MRT£¬FIµÈÖ÷ÒªÒ©´ú²ÎÊý½Ó½ü£¬¾­·½²îÏÔʾÎÞÏÔÖøÐÔ²îÒ죬½øÒ»²½¾­Ë«µ¥²àt¼ìÑéºÍ£¨1-2a£©ÖÃÐÅÇø¼ä·ÖÎöÏÔʾҩ´ú¶¯Á¦Ñ§²ÎÊý½ÓÊÜÉúÎïµÈЧÐÔ¼ÙÉ裬˵Ã÷Á½ÖÖÖÆ¼ÁµÈЧ¡£
ÁÙ´²¹Û²ì£¬ÊÔÑéÆÚ¼äδ¼û²»Á¼·´Ó¦£¬ÎÞÖÐ;ÖÕÖ¹ÊÔÑéµÄÊÜÊÔÕß¡£
ÌåÄÚÍâÏà¹ØÐÔ
ÌåÍâÈܳöÊý¾Ý
ÒÀ¾ÝÑÐÖÆµ¥Î»Öƶ¨µÄÊͷŶȷ½·¨²â¶¨ÊÔÑ黺ÊͽºÄÒµÄÌåÍâÈܳöÊý¾ÝÈç±í
ÌåÄÚÎüÊÕÊý¾Ý
ÒÔWanger-Nelson·¨¼ÆËãÊÔÑéÓûºÊͽºÄÒ²»Í¬Ê±¼äµÄÌåÄÚÎüÊÕÊý¾Ý£¬½á¹ûÈç±í
ÌåÄÚÎüÊÕÊý¾ÝÓëÌåÍâÈܳö·ÖÊýµÄÏà¹ØÐÔÁ¼ºÃ£¬Ïà¹Ø·½³ÌÈçÏ£º
ÌåÄÚÎüÊÕÁ¿%=1.455*ÌåÍâÈܳöÁ¿-12.23   r=0.9638

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ÏÄÌìÏÂÓêÁË(½ð±Ò+1, ·­ÒëEPI+1): 2011-03-09 14:54:20
wg423(·­ÒëEPI-1): ·ÇÓ¦Öú£¬ÊÕ»ØEPI 2011-03-09 15:29:29
ÌåÄÚÍâÏà¹ØÐÔ
ÌåÍâÈܳöÊý¾Ý
correlation in vivo
dissolution data in vitro
2Â¥2011-03-09 12:29:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ÏÄÌìÏÂÓêÁË(½ð±Ò+1): 2011-03-09 14:54:33
ÌåÄÚÎüÊÕÊý¾Ý
absorption data in vivo
3Â¥2011-03-09 12:30:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÏÄÌìÏÂÓêÁË

¶Ò»»¹ó±ö

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡


¼ÌÐøÇóÖú
4Â¥2011-03-09 14:54:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

µØÍ¼ÎÏÅ£

ר¼Ò¹ËÎÊ

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡


¶à¼ÁÁ¿¿Ú·þ10mgÁ½ÖÖÖÆ¼Á£¬Ã¿ÈÕÒ»´Î£¬Ã¿´Î10mg£¿Ëµ²»Í¨Ñ½£¬Ò»·½Ãæ¶à¼ÁÁ¿£¬Ò»·½ÃæÓиø³öÁ˵¥Ò»µÄÈ·ÇеļÁÁ¿¡£
5Â¥2011-03-09 16:18:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

µØÍ¼ÎÏÅ£

ר¼Ò¹ËÎÊ

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡


ÏÄÌìÏÂÓêÁË(½ð±Ò+18, ·­ÒëEPI+1): лл 2011-03-09 18:10:02
¶à¼ÁÁ¿¿Ú·þ10mgÁ½ÖÖÖÆ¼Á£¬Ã¿ÈÕÒ»´Î£¬Ã¿´Î10mg£¬ÓÚ·þÒ©ºóµÚ4ÌìѪҩŨ¶È´ïÎÈ̬¡£Á½ÖÖÖÆ¼ÁµÄFֵΪ98.9%¡À7.9%£¬²ÎÊýTmax£¬Cmax£¬Cmin£¬AUCss£¬AUMCss£¬MRT£¬FIµÈÖ÷ÒªÒ©´ú²ÎÊý½Ó½ü£¬¾­·½²îÏÔʾÎÞÏÔÖøÐÔ²îÒ죬½øÒ»²½¾­Ë«µ¥²àt¼ìÑéºÍ£¨1-2a£©ÖÃÐÅÇø¼ä·ÖÎöÏÔʾҩ´ú¶¯Á¦Ñ§²ÎÊý½ÓÊÜÉúÎïµÈЧÐÔ¼ÙÉ裬˵Ã÷Á½ÖÖÖÆ¼ÁµÈЧ¡£
Two preparations were oral administrated once per day and 10mg per time. Plasma concentration reached steady state at the fourth day after administration. F value for two preparations was 98.9%¡À7.9%, ANOVA analysis showed no significant differences between two preparations on Tmax£¬Cmax£¬Cmin£¬AUCss£¬AUMCss£¬MRT and FI. Further analysis by two- tailed T-test and (1-2a) confidential interval suggested that pharmacokinetic parameters of two preparations were comparable.

ÁÙ´²¹Û²ì£¬ÊÔÑéÆÚ¼äδ¼û²»Á¼·´Ó¦£¬ÎÞÖÐ;ÖÕÖ¹ÊÔÑéµÄÊÜÊÔÕß¡£
No side effects were found during the trial. No subjects quit.

ÌåÄÚÍâÏà¹ØÐÔ
Correlation between in vitro dissolution and in vivo absorption

ÌåÍâÈܳöÊý¾Ý
In vitro dissolution test
ÒÀ¾ÝÑÐÖÆµ¥Î»Öƶ¨µÄÊͷŶȷ½·¨²â¶¨ÊÔÑ黺ÊͽºÄÒµÄÌåÍâÈܳöÊý¾ÝÈç±í
In vitro dissolution test of sustained release capsule was carried out according to the dilution method provided by the producing company. The data was shown in table 1.

ÌåÄÚÎüÊÕÊý¾Ý
In vivo absorption study
ÒÔWanger-Nelson·¨¼ÆËãÊÔÑéÓûºÊͽºÄÒ²»Í¬Ê±¼äµÄÌåÄÚÎüÊÕÊý¾Ý£¬½á¹ûÈç±í
ÌåÄÚÎüÊÕÊý¾ÝÓëÌåÍâÈܳö·ÖÊýµÄÏà¹ØÐÔÁ¼ºÃ£¬Ïà¹Ø·½³ÌÈçÏ£º
ÌåÄÚÎüÊÕÁ¿%=1.455*ÌåÍâÈܳöÁ¿-12.23   r=0.9638

In vivo absorptions in different time were examined by Wanger-Nelson method. Absorption data were shown in table 2.

In vitro dissolution and in vivo absorption were well correlated (In vivo absorption%=1.455* In vitro dissolution-12.23, r=0.9638)
6Â¥2011-03-09 17:19:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÏÄÌìÏÂÓêÁË

ר¼Ò¹ËÎÊ

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡


¶à¼ÁÁ¿ÊÇÖ¸¶à´Î·þÓõÄÒâ˼
7Â¥2011-03-09 18:08:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÏÄÌìÏÂÓêÁË µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 311Çóµ÷¼ÁÒ»Ö¾Ô¸ºÏ·Ê¹¤Òµ´óѧ +14 Çï¶þÊ®¶þ 2026-03-30 14/700 2026-04-01 11:45 by chemdavid
[¿¼ÑÐ] 342Çóµ÷¼Á +9 Mary Keen 2026-03-28 9/450 2026-04-01 09:50 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +10 @taotao 2026-03-31 11/550 2026-04-01 09:43 by xiayizhi
[¿¼ÑÐ] 085900ÍÁľˮÀû336·ÖÇóµ÷¼Á +3 Zhangjiangj 2026-03-31 5/250 2026-04-01 09:14 by Zhangjiangj
[¿¼ÑÐ] 0856²ÄÁÏÓ뻯¹¤µ÷¼Á£¬339 +10 10213207 2026-03-31 10/500 2026-04-01 08:28 by Linda Hu
[¿¼ÑÐ] µ÷¼ÁÍÆ¼ö +7 Ç徯714 2026-03-26 8/400 2026-03-31 22:12 by 544594351
[¿¼ÑÐ] 346Çóµ÷¼Á Ò»Ö¾Ô¸070303Óлú»¯Ñ§ +11 Âܲ·ìÀÇà²Ë 2026-03-28 12/600 2026-03-31 17:54 by xhai2011
[¿¼ÑÐ] 318Çóµ÷¼Á +10 ³Â³¿79 2026-03-30 10/500 2026-03-31 17:37 by 544594351
[¿¼ÑÐ] µ÷¼Á310 +13 ÎÂÈáµÄÍí°² 2026-03-25 14/700 2026-03-31 13:03 by ¼Çʱ¾2026
[¿¼ÑÐ] 287Çóµ÷¼Á +17 land xuxu 2026-03-26 17/850 2026-03-31 11:16 by Zzxxxs
[¿¼ÑÐ] ÄϾ©´óѧ»¯Ñ§µ÷¼Á +11 ¾°Ëæ·ç 2026-03-29 16/800 2026-03-31 10:14 by herarysara
[¿¼ÑÐ] 276Çóµ÷¼Á +3 ÕԾûª 2026-03-29 3/150 2026-03-31 10:06 by cal0306
[¿¼ÑÐ] 269Çóµ÷¼Á +4 ÎÒÏë¶ÁÑÐ11 2026-03-31 4/200 2026-03-31 10:04 by cal0306
[¿¼ÑÐ] 08¹¤¿ÆÇóµ÷¼Á286 +5 tgs_001 2026-03-28 5/250 2026-03-31 08:18 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] 279Çóµ÷¼Á +12 jµÄÁ¢·½ 2026-03-29 12/600 2026-03-30 20:30 by dick_runner
[¿¼ÑÐ] 293Çóµ÷¼Á +3 ĩδmm 2026-03-30 5/250 2026-03-30 17:23 by Íõ±£½Ü33
[¿¼ÑÐ] 295Çóµ÷¼Á +5 wei-5 2026-03-26 5/250 2026-03-30 08:34 by ̽123
[¿¼ÑÐ] 343Çóµ÷¼Á +6 °®î¿°í 2026-03-29 6/300 2026-03-29 12:00 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 394Çóµ÷¼Á +3 ºÃʶàÄ¥¾²ºò¼ÑÒ 2026-03-26 5/250 2026-03-28 14:24 by ÌÆãå¶ù
[¿¼ÑÐ] 07»¯Ñ§303Çóµ÷¼Á +5 î£08 2026-03-25 5/250 2026-03-25 22:46 by 418490947
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û